These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3674897)

  • 21. [Clinical evaluation of S-1, a new anticancer agent, in patients with advanced gastrointestinal cancer. S-1 Cooperative Gastrointestinal Study Group].
    Maehara Y; Sugimachi K; Kurihara M; Taguchi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):476-85. PubMed ID: 10097744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phase I study of 5-fluorouracil and l-leucovorin].
    Sasaki T; Ota K; Wakui A; Akazawa S; Ogawa M; Ariyoshi Y; Yura J; Inagaki J; Hoshino A; Abe T
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):485-91. PubMed ID: 8452386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phase II study of 5-FU tablet in bladder tumor].
    Ohmori H; Matsumura Y; Yoshimoto J; Obama T; Hara M; Josen Y; Ishido N; Nasu Y; Tanahashi T; Asahi T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3115-20. PubMed ID: 3056279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced colorectal and gastric cancer with cisplatinum and 5-fluorouracil. A pilot study.
    Zaniboni A; Zambruni A; Marpicati P; Gorni F; Simoncini E; Ragni F; Marini G
    Chemioterapia; 1986 Oct; 5(5):347-50. PubMed ID: 3791483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [590-S].
    Furue H
    Gan No Rinsho; 1985 May; 31(6 Suppl):739-45. PubMed ID: 4032755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biweekly low-dose cisplatin and 5-fluorouracil combination chemotherapy for advanced gastrointestinal carcinoma].
    Kamata T; Morita A; Nakamoto A; Onishi I; Takeda T; Koyasaki N; Kanno M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):859-64. PubMed ID: 10897212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation as palliative therapy of combination chemotherapy with continuous infusional 5-fluorouracil and consecutive low-dose cisplatin in unresectable gastrointestinal carcinoma].
    Yasumoto K; Takeda J; Iwamoto M; Kawabata S; Takeuchi K; Yunoki T Miwa K; Iwakuma N; Shirouzu K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1909-14. PubMed ID: 9797813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
    Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
    Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preoperative treatment with 5-fluorouracil (5-FU) in gastric and colorectal cancer].
    Kawaura Y; Ohmura K; Hashizume Y; Takayama K; Sakatoku M; Hirano M; Yamada T; Iwa T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):348-52. PubMed ID: 3970555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of continuous infusion of 5-fluorouracil and daily low-dose cisplatin for inoperable recurrent cancer of the stomach and colon].
    Satoh Y; Une Y; Fujisawa J; Sawaguchi Y; Muranaga S; Obara M; Uchino J
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):87-92. PubMed ID: 7826083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.